The National Institute for Biomedical Research and Development, as part of the National Institutes of Health, will engage in the full-cycle development of drugs, devices, and biological products to reduce drug prices, promote access to medicines, foster scientific innovation, and address public health priorities.
Have the National Institute for Biomedical Research and Development carry out full-cycle development of drugs, devices, and biological products to lower drug prices and improve access to medicines.
Occurrences
Evidence
The official House homepage shows Tlaib's most recent posted action on June 18, 2026: the Find Our Families Act on ICE/CBP detainee locator systems. The other visible recent posts in May focus on child poverty, the Nakba, and utility penalties, not drug pricing or biomedical-development policy.
A search within the current official homepage content found no matches for 'drug' or 'medicine', and the visible issue sections are Justice for All, Ending Poverty, and Environmental Justice. That leaves no current House-page sign that the specific biomedical research and drug-development promise has been implemented.
Assessments
The available evidence does not show Rashida Tlaib advancing, sponsoring, or achieving the specific biomedical-development program. Her recent official activity is on unrelated issues, and the current House site shows no sign of the promised drug-development initiative, so the claim cannot be credited as delivered.